Tri Gmnec 2 Tablet ER
Marketer
Capto Therapeutics
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Tri Gmnec 2 Tablet ER
Duo-Control ER tablets are a dual-action formulation designed to manage blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, aids in better glycemic control for adults diagnosed with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing elevated blood sugar. Always adhere to your physician's prescribed dosage and regimen for Duo-Control ER tablets. Ingestion with food is recommended to minimize gastrointestinal discomfort. Should you miss a dose, take it immediately; however, if your next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function assessment will be conducted before treatment initiation. Limit alcohol consumption while on this medication to mitigate potential adverse effects.
Primary Ingredients of Tri Gmnec 2 Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Tri Gmnec 2 Tablet ER
Managing type 2 diabetes
Major Benefits of Tri Gmnec 2 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tri Gmnec 2 Extended-Release Tablets should be administered with a meal.
Common Side effects of Tri Gmnec 2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Tri Gmnec 2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tri Gmnec 2 Extended-Release tablets should be taken with a meal.
How Tri Gmnec 2 Tablet ER works:
Tri Gmnec 2 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications utilize distinct mechanisms to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Tri Gmnec 2 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tri Gmnec 2 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tri Gmnec 2 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Tri Gmnec 2 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician before use. Tri Gmnec 2 Tablet ER is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Tri Gmnec 2 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician before use. Tri Gmnec 2 Tablet ER is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Tri Gmnec 2 Tablet ER :
Should you forget to take a Tri Gmnec 2 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tri Gmnec 2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



